172
Views
13
CrossRef citations to date
0
Altmetric
Original Research

CYP2D6 phenotypes are associated with adverse outcomes related to opioid medications

, , , , , , , , , & show all
Pages 217-227 | Published online: 24 Jul 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Pura Ballester, Javier Muriel & Ana M Peiró. (2022) CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia. Expert Opinion on Drug Metabolism & Toxicology 18:4, pages 261-275.
Read now
Julia Boyle & Christopher J Stock. (2020) CYP2D6 Expression in Veterans Experiencing Opioid Overdose: A Postmortem Review. Pharmacogenomics and Personalized Medicine 13, pages 289-293.
Read now
Guilherme S Lopes, Suzette J Bielinski, Ann M Moyer, John Logan Black III, Debra J Jacobson, Ruoxiang Jiang, Nicholas B Larson & Jennifer L St Sauver. (2020) Sex Differences in Associations Between CYP2D6 Phenotypes and Response to Opioid Analgesics. Pharmacogenomics and Personalized Medicine 13, pages 71-79.
Read now
Teruo Murakami, Erik Bodor & Nicholas Bodor. (2020) Modulation of expression/function of intestinal P-glycoprotein under disease states. Expert Opinion on Drug Metabolism & Toxicology 16:1, pages 59-78.
Read now
Concetta Dagostino, Massimo Allegri, Valerio Napolioni, Simona D’Agnelli, Elena Bignami, Antonio Mutti & Ron HN van Schaik. (2018) CYP2D6 genotype can help to predict effectiveness and safety during opioid treatment for chronic low back pain: results from a retrospective study in an Italian cohort. Pharmacogenomics and Personalized Medicine 11, pages 179-191.
Read now

Articles from other publishers (8)

Ditte B. Iversen, Nanna Elman Andersen, Ann‐Cathrine Dalgård Dunvald, Anton Pottegård & Tore B. Stage. (2022) Drug metabolism and drug transport of the 100 most prescribed oral drugs. Basic & Clinical Pharmacology & Toxicology 131:5, pages 311-324.
Crossref
Ameet S. Nagpal, Daniel J. Lodge, Jennifer S. Potter, Alan Frazer, Robin Tragus, Megan E. Curtis, Angela M. Boley & Maxim Eckmann. (2022) Analgesic Effects of Oxycodone in Combination With Risperidone or Ziprasidone: Results From a Pilot Randomized Controlled Trial in Healthy Volunteers. Frontiers in Pain Research 3.
Crossref
Alexander Sebastian Hauser. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology 191 219 .
Shishi Luo, Ruomu Jiang, Joseph J. Grzymski, William Lee, James T. Lu & Nicole L. Washington. (2021) Comprehensive Allele Genotyping in Critical Pharmacogenes Reduces Residual Clinical Risk in Diverse Populations. Clinical Pharmacology & Therapeutics 110:3, pages 759-767.
Crossref
V. Ferreira, M. Velloso & M. Landoni. (2020) Bioavailability of butorphanol after intranasal administration to horses. BULGARIAN JOURNAL OF VETERINARY MEDICINE 23:4, pages 443-447.
Crossref
Michael A. Ibara & Rachel L. Richesson. 2019. Clinical Research Informatics. Clinical Research Informatics 433 451 .
Frédérique Rodieux, Laszlo Vutskits, Klara M. Posfay-Barbe, Walid Habre, Valérie Piguet, Jules A. Desmeules & Caroline F. Samer. (2018) When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children. Frontiers in Pharmacology 9.
Crossref
Hannah R. Fudin, Jennifer L. Babin, Lisa T. Hong, Jennifer Ku, Alisyn L. May, Alexander Wisner, F. Scott Hall & Sidhartha D. Ray. 2018. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions. A Worldwide Yearly Survey of New Data in Adverse Drug Reactions 29 89 .